HRH4 and cholangiocarcinoma: In agreement with these results, histamine and H4R agonists decreased the proliferation and induced apoptosis and cell senescence of human breast cancer cells [33, 35] while suppressed human cholangiocarcinoma progression, decreasing tumor invasion and growth [36].